How The Maravai LifeSciences (MRVI) Story Is Shifting As Analysts Rework Fair Value Targets [Yahoo! Finance]
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: Yahoo! Finance
Maravai LifeSciences Holdings is back in focus after analysts reset their price target around US$3, aligning it more closely with a refreshed model fair value of US$4.33 per share. The shift follows Q4 results that modestly beat consensus, prompting bullish analysts to see expectations as better tuned to current execution. More cautious voices still view the risk and reward as fairly balanced. Read on to see how these differing views shape the evolving story and what to watch as the narrative moves from model updates to actual results. Stay updated as the Fair Value for Maravai LifeSciences Holdings shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Maravai LifeSciences Holdings. What Wall Street Has Been Saying ?? Bullish Takeaways Baird lifted its price target on Maravai LifeSciences Holdings to US$3 from US$2 after Q4 results modestly beat consensus, indicating that its updated model supports a higher v
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Maravai LifeSciences (MRVI) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=MRVI&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "selMarketBeat
- Maravai Lifesciences Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness Wire
- Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026Business Wire
MRVI
Earnings
- 2/25/26 - Beat
MRVI
Sec Filings
- 3/17/26 - Form 4
- 3/17/26 - Form 4
- 2/26/26 - Form 10-K
- MRVI's page on the SEC website